Who is the owner of Intas Pharmaceuticals?
patriarch Hasmukh Chudgar
While patriarch Hasmukh Chudgar (77) founded the group and is currently its chairman, the tenacity and vision of his three sons — Binish, Nimish and Urmish — has taken Intas to new heights over the last three decades.
Is Intas Pharmaceuticals a good company?
Intas Pharma is a good company, getting time to time payment,having good culture,Innovative molecules,helping nature,time to time training. Good ccompany to join for career orienter.
Who is the CEO of Intas Pharmaceuticals?
Nimish Chudgar
Nimish Chudgar. Managing Director/CEO, Intas Pharmaceuticals Ltd.
Is intas an Indian company?
Intas Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Ahmedabad, Gujarat.
What is the meaning of Intas?
INTAS
| Acronym | Definition |
|---|---|
| INTAS | Integrated Tower Automation Suite (aviation; air traffic control) |
| INTAS | International Animation Sodality |
| INTAS | International Association for Cooperation with Scientists from the former Soviet Union |
What is the rank of Intas Pharma in India?
Intas is present in 85+ countries, with more than 69% of its revenue coming from global business. Currently ranked 9th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company.
What is the use of Intas Pharmaceuticals?
This medication is a fluoroquinolone antibiotic, prescribed for certain types of bacterial infections such as pneumonia, urinary tract, skin, bones and joint infections. It is also used to treat gastrointestinal infections.
How many division of Intas Pharma are there?
Its 8 Strategic Business Units employ a multidivisional model, with 35+ marketing divisions catering to various therapy areas for enhanced focus towards brand development.
What is the rank of Intas Pharma?
Currently ranked at 7th (as per IQVIA TSA MAT October 2021) in the Indian Pharmaceutical Market, Intas is one of the fastest growing Indian pharmaceutical majors, having 3.1% market share. Driven by a sustainable business model, Intas has been consistently outperforming the market with a 13.1% CAGR.